SCHEMBL9330677

SCHEMBL9330677

CCCN1CCC(O[N+](=O)[O-])CC1

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.40
DRD2 P14416 5/20 0.38
CHRM3 P20309 1/20 0.36
PABPC1 P11940 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9348940 0.88 CHRM3 (0.38) HRH3DRD2CHRM3SMN1; SMN2
SCHEMBL9330759 0.87 GNAO1 (0.50) CHRM3
SCHEMBL9330340 0.85 SMN1; SMN2 (0.40) HRH3CHRM3SMN1; SMN2
SCHEMBL5153918 0.82 GSR (0.33)
SCHEMBL5154489 0.82 SLC18A3 (0.38) SMN1; SMN2
SCHEMBL9330490 0.82 ALOX15 (0.41) CHRM3
SCHEMBL9330735 0.79 KEAP1 (0.39) CHRM3SMN1; SMN2
SCHEMBL5148816 0.79 GSR (0.35)
SCHEMBL4889799 0.79 GSR (0.39) HRH3CHRM3
Fumaric Acid SCHEMBL9345675 0.78 KCNH2 (0.43) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0366004-B1 Cyclic azaaliphatic compounds with a nitroxy group, process for their preparation and pharmaceutical compositions thereof BOEHRINGER MANNHEIM GMBH (DE) 1994-03-30 EP disclosed
US-5280031-A Cyclic azaaliphatic compounds with a nitroxy function, processes for the preparation thereof and pharmaceutical compositions containing them BOEHRINGER MANNHEIM GMBH (DE) 1994-01-18 US disclosed
US-5030641-A Treatment of angina pectoris, hypotensive agents BOEHRINGER MANNHEIM GMBH (DE) 1991-07-09 US disclosed
EP-0366004-A1 Cyclic azaaliphatic compounds with a nitroxy group, process for their preparation and pharmaceutical compositions thereof Roche Diagnostics GmbH (DE) 1990-05-02 EP disclosed